Inhibition of FLT3 and PIM Kinases by EC-70124 Exerts Potent Activity in Preclinical Models of Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Inhibition of FLT3 and PIM Kinases by EC-70124 Exerts Potent Activity in Preclinical Models of Acute Myeloid Leukemia

Published:2018-01-16 Issue:3 Volume:17 Page:614-624
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Puente-Moncada Noelia,Costales Paula,Antolín Isaac,Núñez Luz-Elena,Oro Patricia,Hermosilla Maria Ana,Pérez-Escuredo Jhudit,Ríos-Lombardía Nicolás,Sanchez-Sanchez Ana M.,Luño Elisa,Rodríguez Carmen,Martín Vanesa,Morís Francisco

Funder

Ministry of Science and Innovation

Ministry of Education, Government of Castile-Leon

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment;Current Medicinal Chemistry;2024-09

2. Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation;Cancer Research Communications;2024-02-16

3. Imparting aromaticity to 2-pyridone derivatives by O -alkylation resulted in new competitive and non-competitive PIM-1 kinase inhibitors with caspase-activated apoptosis;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-01-17

4. NADPH oxidase mediated oxidative stress signaling in FLT3-ITD acute myeloid leukemia;Cell Death Discovery;2023-06-30

5. Targeting Pim kinases in hematological cancers: molecular and clinical review;Molecular Cancer;2023-01-25